Carlyle Group Inc.
Q4 2021 13F-HR Holdings
Net value change ($000)
-3,014
(-23.9%)
New positions
0
Sold out positions
2
Turnover %
27.4%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q3 2021
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| Ortho Clinical Diagnostics Holdings plc | 343 | 15.7% |
| Atotech Ltd | 211 | 5.7% |
Top Reduces (Value $000, Stocks/ETFs)
| PPD, Inc. | -2,607 | -100.0% |
| GTM | -875 | -23.5% |
| 1Life Healthcare Inc | -37 | -13.4% |
| TALO | -32 | -100.0% |
| Vitru Ltd | -12 | -12.0% |
| Meta Data Ltd | -4 | -100.0% |
| SMHI | -1 | -20.0% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|